This Article Full Text Full Text (PDF) All Versions of this Article: 47/3/334    most recent 01.HYP.0000203146.72879.c3v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Diz, D. I. Search for Related Content PubMed PubMed Citation Articles by Diz, D. I. Related Collections ACE/Angiotension receptors Animal models of human disease Other hypertension Related Article

(Hypertension. 2006;47:334.)
© 2006 American Heart Association, Inc.

Editorial Commentaries

Approaches to Establishing Angiotensin II as a Neurotransmitter Revisited

Debra I. Diz

From the Hypertension & Vascular Disease Center, Wake Forest University School of Medicine, Winston-Salem, NC.

Correspondence to Debra I. Diz, PhD, Hypertension & Vascular Disease Center, Wake Forest University School of Medicine, Medical Center Blvd, Winston-Salem, NC 27157. E-mail ddiz@wfubmc.edu

An extract of the first 250 words of the full text is provided, because this article has no abstract.

During the past 3 to 4 decades, there has been debate on the presence as well as the role of local tissue renin–angiotensin systems (RAS) in cardiovascular physiology and pathophysiology. Although it is now accepted that all components of the RAS are present in a variety of extrarenal tissues and their regulation may be independent of the circulating hormonal system, the factors contributing to this regulation are still not well understood. Also apparent is that our understanding of the relationships among various cell types expressing individual RAS components and production of specific angiotensin peptides in each tissue is still lacking. This is particularly true of the brain RAS, where even after 20years the question of whether there are angiotensinergic versus reninergic neurons or a complete functioning RAS in cerebrospinal fluid (CSF) or extracellular fluid or glia remains in question.¹

Ever since early reports provided biochemical evidence of RAS components in brain, controversy regarding their cellular localization, independence from the circulating system, and authenticity of the proteins and peptides persists. It is well accepted that angiotensinogen is present in CSF/interstitial fluid and localization via immunocytochemistry and in situ hybridization histochemistry reveals that production of the precursor protein is primarily in glia, but also in neurons, within key cardiovascular nuclei. Lingering questions remain concerning local expression of authentic renin in tissues, especially given that prorenin or active renin can be sequestered from the circulation² and other enzymes can exhibit similar proteolytic profiles under certain conditions. However, there is unequivocal evidence of discrete . . . [Full Text of this Article]

Related Article:

Evidence Supporting a Functional Role for Intracellular Renin in the Brain

Julie L. Lavoie, Xuebo Liu, Robert A. Bianco, Terry G. Beltz, Alan Kim Johnson, and Curt D. Sigmund
Hypertension 2006 47: 461-466. [Abstract] [Full Text] [PDF]